Author:
Ni Wenjun,Ji Jia,Dai Zunyan,Papp Audrey,Johnson Amy J.,Ahn Sunjoo,Farley Katherine L.,Lin Thomas S.,Dalton James T.,Li Xiaobai,Jarjoura David,Byrd John C.,Sadee Wolfgang,Grever Michael R.,Phelps Mitch A.
Publisher
Public Library of Science (PLoS)
Reference51 articles.
1. Preclinical and clinical development of cyclin-dependent kinase modulators.;AM Senderowicz;J Natl Cancer Inst,2000
2. Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.;B Carlson;Cancer Res,1999
3. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.;BA Carlson;Cancer Res,1996
4. Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Correlation with decreased H1 kinase activity.;PJ Worland;Biochem Pharmacol,1993
5. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway.;RH Decker;Cell Death Differ,2001
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献